ArticleActa pharmacologica Sinica2025

An endoplasmic reticulum-targeting photodynamic AMPK agonist activates breast cancer immunotherapy through promoting immunogenic cell death and downregulation of PD-L1.

Ye-Yang Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.